Molecular Mining has a long-term research mission: to advance the science required to create a living human being from a sufficiently complete digital biological specification.
A useful thought experiment begins with an ordinary video. Imagine a future system that accepts footage of a person, extracts observable characteristics such as facial geometry, body proportions, movement, voice, and visible phenotype, then combines those observations with biological data and scientific models to guide the development of a living human organism matching the intended specification.
A video would supply only part of that specification. A complete biological description would require information that ordinary images cannot reveal: genome sequence, gene regulation, cell states, internal anatomy, physiology, immune and endocrine function, neural organization, and the effects of development and life history. The mission therefore spans several scientific disciplines and several unsolved problems.
The research problem
The central question is simple to state: what information, models, and biological technologies would be required to move from observations of a person to a living human system with specified biological characteristics?
- Capture: measure phenotype, genome, molecular states, anatomy, physiology, behavior, and other observable characteristics.
- Model: integrate heterogeneous measurements into a coherent representation of the individual.
- Specify: determine which genetic, epigenetic, cellular, anatomical, and physiological states must be reproduced.
- Develop: understand how cells differentiate, organize, and form tissues and organs over time.
- Build: develop regenerative, tissue-engineering, organoid, and biofabrication technologies capable of producing functional biological structures.
- Mature: understand and control physiological maturation, including the nervous system.
- Validate: determine whether the resulting organism matches the intended specification in structure, function, health, and behavior.
Why human development is central
A genome does not directly describe a finished adult body. Development converts inherited information and regulatory programs into specialized cells, tissues, organs, and integrated physiology. The Human Cell Atlas Development Biological Network studies the cell types and states present during human development, while large single-cell studies are already mapping developmental trajectories across tissues.
This makes developmental biology a central discipline for the Molecular Mining program. Understanding a target state is only one part of the problem; understanding how living systems reach that state is equally important.
From cells to tissues and organs
Regenerative medicine provides another essential part of the research landscape. The U.S. Food and Drug Administration describes regenerative medicine as an approach to restore, replace, or recreate cells, tissues, or organs, encompassing areas such as cell therapy and therapeutic tissue engineering.
Current regenerative technologies address specific cells, tissues, diseases, and engineered structures. The mission described here requires integration across the entire organism, reliable maturation, vascularization, innervation, immune compatibility, endocrine function, and long-term safety. Those requirements remain major research challenges.
The brain, memory, and personal identity
Creating a body with specified biological characteristics would leave a separate set of questions concerning the brain. Neural development, connectivity, learning, memory, personality, and consciousness cannot be inferred completely from external appearance.
A person’s genome contributes to neural development, while lived experience changes the nervous system throughout life. A future technology seeking behavioral or cognitive fidelity would therefore need additional information and scientific understanding beyond the biological construction of the body.
Molecular Mining treats biological resemblance, functional resemblance, memory, and personal identity as distinct research questions. Each requires its own evidence and validation criteria.
The disciplines that converge here
- Genetics and genomics — inherited variation and biological specification.
- Bioinformatics and computational biology — integration and interpretation of biological data.
- Human phenomics — systematic characterization of observable traits.
- Developmental biology — cell fate, morphogenesis, organogenesis, and maturation.
- Regenerative medicine and biofabrication — engineered cells, tissues, organoids, scaffolds, and biological structures.
- Biotechnology — gene editing, cell engineering, manufacturing, and translational technologies.
- Neuroscience — neural development, connectivity, learning, memory, and cognition.
- Artificial intelligence — multimodal measurement, inference, biological modeling, and control.
Scientific reality
No existing technology can accept a video and produce a mature living human who reproduces the person shown in that video. The gap between current capabilities and this mission is large. That gap is the subject of the research program.
Molecular Mining will distinguish demonstrated capabilities, plausible research directions, unresolved questions, and speculative goals. Articles will examine the evidence required at every stage and will update conclusions as the underlying science changes.
Responsible development
Any technology capable of reproducing human biological characteristics would raise profound questions of consent, safety, privacy, ownership of biological data, reproductive ethics, and the rights of the resulting person. These questions belong inside the scientific program from the beginning.
The site will therefore examine technical capability together with validation standards, ethical constraints, and the consequences of creating living human systems from personal data.
Where Molecular Mining begins
The existing archive already covers several parts of this program. Start with Cloning & Genetic Editing: Progress and Barriers, CRISPR Data Analysis via Bioinformatics, Intelligent Systems in Computational Biology, and Generative AI Applications in Pharma.
Future work will expand the remaining bridges: developmental biology, stem-cell biology, tissue engineering, organogenesis, neurodevelopment, connectomics, and biological digital twins.
The mission is ambitious by design: define the information required to specify a human biological system, understand the processes that build it, develop the technologies that can reproduce it, and establish rigorous ways to determine what has actually been created.